▲ BUY
5
/ 10
Conviction
$ Value
$152K
Shares
1,235
Price
$123
Filed
May 5
▶ Why this score? (5/10)
- ✓ Open market buy (+3)
- ✓ Director (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
DORSA CAROLINE
Title
—
CIK
0001181174
Roles
Director
Transaction Details
Transaction Date
2025-05-02
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
27,842
Filing Info
DORSA CAROLINE's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-06-17 | BIIB | A | $0 |
| 2025-05-21 | ILMN | A | $0 |
| 2025-05-16 | ILMN | F | $89K |
| 2025-05-02 | BIIB | ▲ | $152K ★ |
| 2025-05-01 | DUK | A | $195K |
Other Insiders at BIIB (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Murphy Nicole
Head of Pharm Ops and Tech
|
$585 | — | 2026-02-13 |
|
ALEXANDER SUSAN H
EVP Chief Legal Officer
|
— | — | 2026-02-13 |
|
Gregory Ginger
EVP, Human Resources
|
— | — | 2026-02-13 |
|
Kramer Robin
Chief Financial Officer
|
— | — | 2026-02-13 |
|
Singhal Priya
Head of Development
|
— | $666K | 2026-02-13 |
|
Viehbacher Christopher
President and CEO
|
— | — | 2026-02-13 |
|
Izzar Rachid
Head of Global Product Strat.
|
— | — | 2026-02-13 |
|
Keeney Adam
Head of Corporate Development
|
— | — | 2026-02-13 |
|
Grogan Jane
Head of Research
|
— | — | 2026-02-13 |
|
Godbout Sean
Chief Accounting Officer
|
— | — | 2026-04-01 |